Welcome to our dedicated page for AMN HEALTHCARE SERVICES SEC filings (Ticker: AMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMN HEALTHCARE SERVICES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMN HEALTHCARE SERVICES's regulatory disclosures and financial reporting.
Morgan Stanley, through certain reporting units, reports a passive ownership stake in AMN Healthcare Services, Inc. common stock. As of June 30, 2026, the filing shows 2,076,006 shares beneficially owned, representing 5.4% of AMN’s common stock. Morgan Stanley reports no sole voting or dispositive power, with shared voting power over 2,075,030 shares and shared dispositive power over 2,076,006 shares. The disclosure applies only to certain Morgan Stanley operating units, with other units, if any, disaggregated under applicable SEC guidance.
AMN Healthcare Services generated Q2 2026 revenue of $673.2 million, up 2% from $658.2 million a year earlier, and returned to profitability with $21.2 million of net income versus a prior-year loss. For the first half of 2026, revenue rose 52% to $2,051.6 million.
Growth was concentrated in nurse and allied solutions, where revenue nearly doubled to $1,549.3 million driven largely by large-scale labor disruption staffing, while physician and leadership and technology and workforce solutions revenues declined 6% and 15% year-to-date. Consolidated first-half gross margin was 28.0% versus 29.3% a year earlier, as pricing pressure and client losses weighed on technology offerings, partly offset by higher-margin labor disruption work. Operating cash flow more than doubled to $372.5 million, bolstering liquidity; the company ended June 30 with no borrowings on its $450 million revolver and $750 million of senior notes outstanding.
AMN Healthcare Services, Inc. posted second quarter 2026 revenue of $673 million, up 2% from a year earlier and down 51% sequentially following unusually large labor disruption events in the first quarter. Net income was $21 million, or $0.53 per diluted share, compared with a net loss of $116 million, or ($3.02) per share, in Q2 2025. Adjusted diluted EPS rose to $0.77 from $0.30, and adjusted EBITDA was $73 million, a 26% year-over-year increase with a 10.9% margin.
Nurse and Allied Solutions revenue was $422 million, up 11% year over year, helped by travel nurse and allied growth and $25 million of labor disruption revenue. Physician and Leadership Solutions revenue was $165 million, down 6% year over year, while Technology and Workforce Solutions revenue declined 15% to $87 million, with language services at $70 million and vendor management systems at $15 million.
Cash and cash equivalents totaled $362 million at June 30, 2026, against total debt of $750 million, resulting in a 1.5x leverage ratio under the company’s credit agreement. Operating cash flow was ($190 million) for the quarter and $373 million year to date, reflecting the return of client deposits from first-quarter labor disruption events. For the third quarter of 2026, management guides consolidated revenue to $640–$655 million and adjusted EBITDA margin to 6.5%–7.0%.
AMN Healthcare Services director Daphne E. Jones reported compensation-related equity activity and corrected a prior share count. She exercised 8,325 Restricted Stock Units (RSUs) into the same number of shares of AMN common stock, which are held in the Daphne E. Jones Revocable Trust. Following this transaction, the filing states she beneficially owned 16,124 shares of common stock through the trust.
On the same date, Jones received a new grant of 8,304 RSUs under the AMN Healthcare 2025 Equity Plan, each representing one future share of common stock, bringing her direct RSU holdings to 8,304 units. The amendment also notes an earlier Form 4 had overstated her post-transaction ownership by 1,000 shares, and this filing corrects that figure.
AMN Healthcare Services director Mark G. Foletta, through The Foletta Family Trust, reported open-market sales of a total of 3,681 shares of AMN common stock on June 15, 2026. The trust sold 2,000 shares at a weighted average price of $31.069 and 1,681 shares at a weighted average price of $31.067, in multiple trades within disclosed price ranges. Both sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2026. After these transactions, indirect holdings reported for the trust were 19,917 shares in one line and 17,917 shares in another.
AMN Healthcare Services reported a sharp turnaround in Q1 2026, driven by large labor disruption projects. Revenue doubled to $1,378.4 million from $689.5 million, led by nurse and allied solutions, which surged to $1,127.3 million as AMN staffed multiple large-scale labor disruption events.
Net income swung to a profit of $62.2 million, or $1.60 per basic share, compared with a small loss a year earlier. Operating cash flow jumped to $562.5 million, reflecting sizable client deposits and higher segment operating income, and cash and cash equivalents rose to $560.7 million with the revolving credit facility fully repaid.
While nurse and allied solutions grew 173%, physician and leadership solutions revenue declined 6% and technology and workforce solutions fell 15%, pressured by lower locum tenens volume, weaker VMS and language pricing, and the sale of the Smart Square scheduling software. Consolidated gross margin narrowed to 26.8% from 28.7% as mix shifted and technology margins compressed, partly offset by higher-margin labor disruption work.
AMN Healthcare Services reported a very strong first quarter of 2026, with revenue of $1.378 billion, up 100% from a year earlier, and net income of $62 million or $1.59 per diluted share versus a prior-year loss. Adjusted diluted EPS rose to $2.10 from $0.45, while adjusted EBITDA reached $166.1 million, a 159% increase and a 12.1% margin. Nurse and Allied Solutions revenue grew to $1.127 billion, helped by $722 million from labor disruption events, and most staffing categories showed year-over-year growth, though Physician and Leadership Solutions and Technology and Workforce Solutions declined.
Cash flow from operations was $562 million, boosting cash to $561 million against $750 million of debt and a 1.6x leverage ratio. For second quarter 2026, AMN guided consolidated revenue to $620–$635 million with operating margin around breakeven and adjusted EBITDA margin of 6.7%–7.2%, signaling a step-down from the disruption-driven Q1 peak.
Palmer Eric P reported acquisition or exercise transactions in this Form 4 filing.
AMN Healthcare Services director Eric P. Palmer received a grant of 8,304 restricted stock units (RSUs). The award was made on May 1, 2026 under the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN common stock at vesting.
The 8,304 RSUs vest on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual Meeting of Shareholders. Restricted stock units do not have an expiration date, and Palmer’s direct holdings of RSUs following this grant total 8,304 units.
Hinton James H. reported acquisition or exercise transactions in this Form 4 filing.
AMN Healthcare Services director James H. Hinton received an equity award of 8,304 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of AMN common stock under the AMN Healthcare 2025 Equity Plan.
The RSUs were granted on May 1, 2026 and vest on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual Meeting of Shareholders. At Hinton’s irrevocable election, the vested RSUs will settle in shares on the date he separates from service as a director.